CLINICAL ROLE -
How Does Sleep Impact Cancer Survival?
Duration of sleep and snoring may play a role in survival outcomes.
Read More
Enhanced Side Effect Management Program Highlights Specialty Week in Review
Top stories of the week on Specialty Pharmacy Times from June 8-12.
FDA Addresses Efficacy Concerns of New Hepatitis C Drug Approvals
Agency notes that expedited approvals do not compromise quality standards.
HIV-Infected Transgender Women Less Adherent to Medications
Study finds greater unmet needs for basic services compared with male patients.
Early Quality of Life Care Lowers Overall Cancer Treatment Costs
Early palliative care reduces costs more than traditional treatment standards.
Variant Makes Chemotherapy Preferred Option for Some Advanced Prostate Cancer Patients
Men with AR-V7 variant more likely to be resistant to hormone drugs.
Hepatitis C Uses Decoys to Survive Immune System Attacks
Researchers find cooperation among viral variants that help hepatitis C to survive.
Overcoming Specialty Drug Cost Challenges
David D'Altorio, PharmD, senior vice president of health services at MedImpact Healthcare Systems, Inc, discusses methods to address the growing cost of specialty medications.
Gene Therapy With Herpes Virus Extends Survival in Advanced Brain Cancer Patients
Glioblastoma treatment with surgical resection may benefit patients with worst prognoses.
Improved Side Effect Management May Help Cancer Patients Remain on Therapy
Undertreated side effects in treatment of some colon and stomach cancers need to be addressed.
Medicare Costs on the Rise for Older Oral Cancer Patients
Costs grow for people with oral cavity and pharyngeal cancers based on demographics, co-existing illnesses, and treatment selection.
Can Breastfeeding Lower Risk of Childhood Cancer?
Biological mechanisms of breast milk may have preventative effect.
Immunotherapy Nearly Doubles Survival Rate in Lung Cancer Patients
Nivolumab extends life by 3.2 months compared with chemotherapy.
Improving the Landscape for Specialty Pharmacy
National Association of Specialty Pharmacy (NASP) Executive Director James E. Smeeding, RPh, MBA, discusses the National Association for Specialty Pharmacy and their efforts to enhance the specialty space.
Melanoma Drug Shows Manageable Side Effects
Nivolumab has increased the survival rate in patients with low grade adverse events.
Affordable Care Act Prescription Trends Highlights Week in Specialty Pharmacy
A look back at the top stories of the week on Specialty Pharmacy Times.
Plant Extracts Show Potential in Treatment of Diabetes, Cancer
Extracts show strong activity in treatment of cervical cancer cells.
Experimental Rheumatoid Arthritis Drug Improves Symptoms
Drug found to improve physical function.
How Can Radiotherapy Be Enhanced Across Wide Range of Cancer Types?
Combination therapy with AKT inhibitors shows promise.
Affordable Care Act Enrollees Have Lower Average Drug Spending
Marketplace users less likely to use most medication classes except for hepatitis C and HIV.
How Can Specialty Pharmacies Improve Adherence?
David Lassen, chief clinical officer at Prime Therapeutics, discusses methods to overcome the impact of increasingly high copays on patient adherence.
Advanced Prostate Cancer Combination Therapy Shows Promise
Chemotherapy combination extends progression-free survival over standard chemotherapy.
Why Do Ovarian Cancer Drugs Fail?
Research seeks to determine how cancer cells avoid chemotherapy.
Non-Hodgkin's Lymphoma Treatment Shows Significant Survival Benefit
High level of benefit found in Gazyva compared with bendamustine.
Young Patients Drive Spike in Melanoma Incidence Rate
Melanoma incidence increased 250% in children, adolescents and young adults since 1973.
Prostate Cancer Genome Offers New Treatment Target
Gene mutations found in some patients provide hope for new and existing treatments.
How to Determine Which Hepatitis C Patients are Most in Need of High Cost Drugs
Predictive model uses routine lab values and machine learning method.
Chemical Compound Shows Promise in Rheumatoid Arthritis Treatment
Therapy disrupts signals that fuel inflammation.
How to Improve Efficiency in the Specialty Drug Landscape
Amy Grogg, PharmD, senior vice president of Strategy and Commercialization at AmerisourceBergen Specialty Group discusses how the relationship between manufacturers, providers, and specialty pharmacies can be improved.
New RNA Classes Linked With Cancer Biomarkers
A pair of large RNA classes associated with a protein that may play a role in cancer progression.